RUTH IKEANYIONWU: Open Payments
NPI 1134757131 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 9 payments from 7 companies in 2025. Trend: 2023 $70 · 2024 $200 · 2025 $252
Food & beverage: $167Education: $85
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $85 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Eisai Inc. | 2 | $35 |
| Syndax Pharmaceuticals, Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $18 |
| Genmab U.S., Inc. | 1 | $18 |
Products named: SOLIRIS, Enhertu, Lenvima, ERLEADA, WAYRILZ, Epkinly.
Industry payments across TX — which companies pay providers there.
